Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 7 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

4Total
Not Applicable (3)
P 1 (1)

Trial Status

Recruiting4
Not Yet Recruiting2
Active Not Recruiting1

Clinical Trials (7)

Showing 7 of 7 trials
NCT07198971Not ApplicableRecruitingPrimary

Feasibility Study Incorporating Music Therapy to Optimise the Smoking Cessation Process Coordinated by a Tobacco Addiction Nurse in Smoking Patients Being Treated for Cancer

NCT07290309Not ApplicableRecruiting

Survivors Uniting for Remote Guided Exercise

NCT07433660Recruiting

WellSpan-THRIVE Cancer QOL Study

NCT07198958Not Yet Recruiting

Immune Adverse Events Registry in Onco-Hematologic Patients Treated With Immunotherapy

NCT07173348Not ApplicableNot Yet RecruitingPrimary

Hypnosis on Breathlessness Mastery in Patients With Persistent Dyspnea

NCT07107607Recruiting

Assessing Claims of Cannabis as an Anti-cancer Agent (CATA)

NCT05300438Phase 1Active Not RecruitingPrimary

Phase I Study of TSN084 in Patients With Advanced Malignant Tumors.

Showing all 7 trials

Research Network

Activity Timeline